Pilot Study Exploring the Use of Hyperbaric Oxygen in Autologous Peripheral Blood Stem Cell Transplantation

Status unconfirmed · Not applicable

Conditions studied: Multiple Myeloma, Hodgkin's Disease, Non-Hodgkin's Lymphoma

In brief

By doing this study, researchers hope to learn the following: * The safety of hyperbaric oxygen administration in the setting of the autologous transplant * The effects of hyperbaric oxygen administration on neutrophil count recovery and engraftment

Key facts

Study ID
NCT02087657
Run by
University of Kansas Medical Center
People needed
20
Starts
2014-03-01
Expected to finish
2017-08-01
Last updated by the study team
2017-02-14

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.